REVB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Revelation Biosciences Inc (REVB) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks positive technical signals, has weak financial performance, no recent news catalysts, and no significant trading trends. Given the lack of growth potential and negative outlook, holding off on this investment is recommended.
The technical indicators suggest a bearish trend. The MACD histogram is below 0 and negatively contracting, RSI is neutral at 22.552, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 1.724, with key support at 1.449 and resistance at 1.999.
NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data available.
Weak financial performance with no revenue growth, negative net income, and a significant drop in EPS (-95.59% YoY). Bearish technical indicators and lack of trading trends further add to the negative outlook.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income of -$4,676,918 (up 108.65% YoY but still negative), and a significant EPS drop to -1.77 (-95.59% YoY). Gross margin remains at 0%.
No analyst rating or price target changes available.
